Clinical Trial Update: A Prospective Study of MSS-type Metastatic Colorectal Cancer Receiving Multiple Lines of Standard Chemotherapy, Bevacizumab Combined With Adebrelimab [Phase 2]

View source ↗

Summary

Phase 2 prospective study in MSS-type metastatic colorectal cancer evaluating bevacizumab with adebrelimab in patients who have received multiple lines of stand…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Adebrelimab (adebrelimab)
• Bevacizumab (bevacizumab)

Snippet

Sponsor: Fudan University | Conditions: Metastatic Colorectal Cancer | Phase 2 | Status: NOT_YET_RECRUITING